Yang Jeong Hoon, Lee Seung Tae, Kim Jee Ah, Kim Sung Hae, Jang Shin Yi, Ki Chang Seok, Kim Duk Kyung
Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Korean Med Sci. 2007 Aug;22(4):698-705. doi: 10.3346/jkms.2007.22.4.698.
Ehlers-Danlos syndrome (EDS) is a hereditary disorder of the connective tissue. EDS type IV (EDS IV), the vascular type of the disease, is characterized by easy bruising, thin skin with visible veins, and spontaneous rupture of the large arteries, uterus, or bowel. EDS IV is caused by mutations in the gene for type III procollagen (COL3A1). However, recent studies suggest that the causative mutation of EDS IV is not homogeneous. We report our experience with three patients presenting with clinical features of type IV EDS. A 48-yr-old woman presented with acute aortic dissection (patient 1) and 36-yr-old and 21-yr-old women presented with carotidcavernous fistula (patients 2 and 3, respectively). All three patients bruised easily. Two patients (patients 1 and 3) had thin transparent skin with visible veins. Genetic analysis of COL3A1 revealed a Gly732Val (c.2195G>T) mutation in patient 1 and a duplication of 15 base pairs (c.3221_3235dup) which resulted in an interposition of five amino acids (p.Gly1074_Pro1078dup) in patient 2. However, no mutations were observed in COL3A1 or transforming growth factor beta receptors 1 and 2 in patients 3, which might be either due to a deletion of single or multiple exons in the COL3A1 gene or due to a genetic heterogeneity. This is the first report of genetically confirmed cases of EDS IV in Korea.
埃勒斯-当洛综合征(EDS)是一种遗传性结缔组织疾病。IV型埃勒斯-当洛综合征(EDS IV)是该疾病的血管型,其特征为容易出现瘀伤、皮肤薄且可见静脉,以及大动脉、子宫或肠道的自发性破裂。EDS IV由III型前胶原(COL3A1)基因的突变引起。然而,最近的研究表明,EDS IV的致病突变并不单一。我们报告了3例具有IV型EDS临床特征患者的情况。一名48岁女性表现为急性主动脉夹层(患者1),两名分别为36岁和21岁的女性表现为颈内动脉海绵窦瘘(分别为患者2和患者3)。所有3例患者均容易出现瘀伤。2例患者(患者1和患者3)皮肤薄且透明,可见静脉。对COL3A1的基因分析显示,患者1存在Gly732Val(c.2195G>T)突变,患者2存在15个碱基对的重复(c.3221_3235dup),导致插入5个氨基酸(p.Gly1074_Pro1078dup)。然而,患者3的COL3A1以及转化生长因子β受体1和2未观察到突变,这可能是由于COL3A1基因单个或多个外显子的缺失,或者是由于基因异质性。这是韩国首例经基因确诊的EDS IV病例报告。